Dongkoo Bio&Pharma Co (XKRX:006620) Selling and Marketing Expense : ₩111,617 Mil (TTM As of Mar. 2025)

View and export this data going back to 2018. Start your Free Trial

What is Dongkoo Bio&Pharma Co Selling and Marketing Expense?

Selling and Marketing Expense is the aggregate total amount of expenses directly related to the marketing or selling of products or services. Dongkoo Bio&Pharma Co's Selling and Marketing Expense for the three months ended in Mar. 2025 was ₩26,966 Mil. Its Selling and Marketing Expense for the trailing twelve months (TTM) ended in Mar. 2025 was ₩111,617 Mil.

Dongkoo Bio&Pharma Co Selling and Marketing Expense Historical Data

The historical data trend for Dongkoo Bio&Pharma Co's Selling and Marketing Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Dongkoo Bio&Pharma Co Selling and Marketing Expense Chart

Dongkoo Bio&Pharma Co Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Selling and Marketing Expense

Get a 7-Day Free Trial

48,949.78

59,303.26

75,408.91

89,320.50

112,204.48

Dongkoo Bio&Pharma Co Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Selling and Marketing Expense	Get a 7-Day Free Trial															27,554.08	28,229.84	28,329.92	28,090.64	26,966.36

Dongkoo Bio&Pharma Co Selling and Marketing Expense Calculation

Selling and Marketing Expense is the aggregate total amount of expenses directly related to the marketing or selling of products or services.

Selling and Marketing Expense for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩111,617 Mil.

Dongkoo Bio&Pharma Co Selling and Marketing Expense Related Terms

Thank you for viewing the detailed overview of Dongkoo Bio&Pharma Co's Selling and Marketing Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Dongkoo Bio&Pharma Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Dongkoo Bio&Pharma Co Ltd (XKRX:006620) » Definitions » Selling and Marketing Expense

Traded in Other Exchanges

N/A

Address

B-14F, M State Building, 114, Beobwonro, Songpagu, Seoul, KOR, 05836

Website

http://www.dongkoo.com

Dongkoo Bio&Pharma Co Ltd is engaged in the research, development, manufacture, and sale of pharmaceuticals products. The company provides products for digestants, other analgesics and antipyretics, nonsteroidal anti-inflammatory drugs, oral hypoglycemic agents, antiplatelet agents, antihistamines and anti-allergic, and decongestants and nasal sprays. It offers its products in multiple forms such as capsules, tablet, powder, granule, and liquid. The company exports its products to various countries including Vietnam, New Zealand, Thailand, Hong Kong and Singapore.

Dongkoo Bio&Pharma Co Headlines

No Headlines